Literature DB >> 29302689

Solving the Hydroxychloroquine Dosing Dilemma With a Smartphone App.

Elliot M Perlman1, Paul B Greenberg2, David Browning3, Robert P Friday4, Joan W Miller5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29302689      PMCID： PMC5838714          DOI： 10.1001/jamaophthalmol.2017.6076

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  5 in total

1.  Adherence to Hydroxychloroquine Dosing Guidelines by Rheumatologists: An Electronic Medical Record-Based Study in an Integrated Health Care System.

Authors:  Rebekah A Braslow; Mira Shiloach; Marian S Macsai
Journal:  Ophthalmology       Date:  2017-01-30       Impact factor: 12.079

2.  The Prevalence of Hydroxychloroquine Retinopathy and Toxic Dosing, and the Role of the Ophthalmologist in Reducing Both.

Authors:  David J Browning
Journal:  Am J Ophthalmol       Date:  2016-04-28       Impact factor: 5.258

3.  The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.

Authors:  Ronald B Melles; Michael F Marmor
Journal:  JAMA Ophthalmol       Date:  2014-12       Impact factor: 7.389

4.  Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).

Authors:  Michael F Marmor; Ulrich Kellner; Timothy Y Y Lai; Ronald B Melles; William F Mieler
Journal:  Ophthalmology       Date:  2016-03-16       Impact factor: 12.079

5.  The impact of different algorithms for ideal body weight on screening for hydroxychloroquine retinopathy in women.

Authors:  David J Browning; Chong Lee; David Rotberg
Journal:  Clin Ophthalmol       Date:  2014-07-24
  5 in total
  1 in total

1.  Somatotype, the risk of hydroxychloroquine retinopathy, and safe daily dosing guidelines.

Authors:  David J Browning; Chong Lee
Journal:  Clin Ophthalmol       Date:  2018-05-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.